Cargando…
Estimating the net value of treating hepatitis C virus using sofosbuvir-velpatasvir in India
Recently developed direct-acting antiviral (DAA) treatments for hepatitis C virus (HCV) have been groundbreaking for their high efficacy across disease genotypes and lack of severe side effects. This study uses a cost-of-illness (COI) approach to estimate the net value conferred by this class of dru...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297876/ https://www.ncbi.nlm.nih.gov/pubmed/34292958 http://dx.doi.org/10.1371/journal.pone.0252764 |